[{"NetIncomeLossConverted_1_FY_USD":-105649000.0,"NetIncomeLossConverted_4_FY_USD":-298665000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-190941000.0,"EarningsPerShareDiluted_1_FY_USD":-0.83,"CommonStockSharesOutstanding_0_FY_shares":127416740.0,"StockholdersEquity_0_FY_USD":716852000.0,"EarningsPerShareBasic_4_FY_USD":-2.51,"Assets_0_FY_USD":918761000.0,"CommonStockSharesConverted_0_FY_shares":127416740.0,"RevenuesConverted_4_FY_USD":76368000.0,"RevenuesConverted_1_FY_USD":1734000.0,"EarningsPerShareBasic_1_FY_USD":-0.83,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210225"}]